Study of an asthma treatment for people with moderate to severe asthma
Part of Blood & lymphatic, Lungs & breathing clinical trials.
This trial tests an experimental medication called SIM0718 to see if it can improve asthma control and reduce flare-ups. It may be an option for people whose asthma is not well-controlled with their current inhaler therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 75 years old and weigh at least 40 kg.
- You have had asthma for at least 12 months.
- You use a medium to high dose of inhaled steroids plus one or two other asthma controller medicines, and your doses have been stable for at least 28 days.
- Your lung function (FEV1) is moderately reduced (80% or less of normal for adults, 90% or less for teens).
- Your asthma symptoms are not well-controlled (score of 1.5 or higher on the ACQ-5 questionnaire).
- You have had at least one severe asthma flare-up in the past year, but none in the last 28 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This study tests an oral tablet (HSK31858) to see if it helps control asthma in people whose asthma is not well managed with current inhalers. It focuses on those with a specific type of asthma where certain blood cells are low.
Hear when a new Asthma; Eosinophilic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.